We hope that you will fill out our survey and help the Canadian Cancer Survivor Network by providing insights and perspectives about living with and managing advanced stages of prostate cancer. If you do not have advanced prostate cancer, please help us share the survey with others who do. Please note that most of this survey is for patients, while there are several questions at
Month: February 2013
CCSN’s questions to Liberal Party of Canada leadership candidates
The current Liberal Party of Canada leadership race provides you, the patient / survivor advocate, with a unique opportunity to ask questions and engage the candidates who hope to be the next leader of the Liberal Party of Canada. CCSN is here to not only make your voice heard, but also to help you engage the candidates. CCSN has prepared questions that we have asked
Rapport historique sur les effets pour l’homme de l’exposition aux perturbateurs endocriniens chimiques
19 FÉVRIER 2013 | GENÈVE – Selon un nouveau rapport publié par le Programme des Nations Unies pour l’Environnement (PNUE) et l’Organisation mondiale de la Santé (OMS), intitulé State of the Science of Endocrine Disrupting Chemicals, de nombreuses substances chimiques synthétiques dont les effets perturbateurs sur le système endocrinien n’ont pas été testés pourraient avoir des conséquences non négligeables sur la santé. Les auteurs de cette étude
Effects of human exposure to hormone-disrupting chemicals examined in landmark UN report
19 FEBRUARY 2013 | GENEVA – Many synthetic chemicals, untested for their disrupting effects on the hormone system, could have significant health implications according to the State of the Science of Endocrine Disrupting Chemicals, a new report by the United Nations Environment Programme (UNEP) and WHO. “We urgently need more research to obtain a fuller picture of the health and environment impacts of endocrine disruptors.” Dr Maria
Disparity in care for men with advanced prostate cancer
For Canadian men living with advanced prostate cancer that has spread to their bones, access to bone-targeted treatment may depend on where they live rather than on evidence-based standard of care. For example, men who live in some provinces, such as Alberta, must pay for bone-targeted therapies out of their own pocket or through private insurance, but men living in Ontario or Quebec do not